Literature DB >> 16045329

Proximity-induced catalysis by the protein kinase ERK2.

Mark A Rainey1, Kari Callaway, Richard Barnes, Brian Wilson, Kevin N Dalby.   

Abstract

Five hundred protein kinases phosphorylate 10 000 proteins in human cells. Frequently, more than one site in a protein is phosphorylated, and often by more than one protein kinase. The mechanistic basis underlying the overlapping specificity of the phospho-proteome is not well understood. We are interested in understanding why ERK2, a proline-directed protein kinase, phosphorylates only a fraction of the (S/T-P) sites found in the surface loops of proteins, at an appreciable rate. To address this fundamental question, we utilized a well-established protein substrate EtsDelta138, which comprises a globular ERK2-recognition domain (pnt domain) and an unstructured peptide-like N-terminal tail. This tail contains T38, the sole ERK2 phosphorylation site. We mutated the TP motif, which is recognized by the active site and found that mutagenesis of the T-38/P-39 motif to TD, TR, TA, TG, and TV has no effect on the stability of the ternary complex but does decrease kcat. We also investigated the effect of perturbing the binding between ERK2 and the pnt domain, which occurs outside the active site, to find that mutation of the pnt domain (F120A) leads to a 10-fold decrease in binding but the kcat remains the same. The data support a mechanism of proximity-mediated catalysis, where the docking of the pnt domain, outside the active site, increases the effective concentration of the TP motif near the active site. The data are consistent with the notion that the interaction between ERK2 and the pnt domain provides uniform binding energy and stabilizes each enzyme intermediate and transition state to an equal extent. While other steps on the reaction pathway contribute towards the specificity of the ERK2 reaction, a docking interaction provides the initial basis for substrate recognition. Those residues within the docked complex, which have the ability to access the active site with an appropriate geometry, can be phosphorylated at an efficient rate if followed by a proline or small hydrophobic amino acid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045329      PMCID: PMC7085985          DOI: 10.1021/ja052915p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

Review 1.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

Review 3.  ERK as a model for systems biology of enzyme kinetics in cells.

Authors:  Alan S Futran; A James Link; Rony Seger; Stanislav Y Shvartsman
Journal:  Curr Biol       Date:  2013-11-04       Impact factor: 10.834

4.  Mae inhibits Pointed-P2 transcriptional activity by blocking its MAPK docking site.

Authors:  Feng Qiao; Bryan Harada; Haiyun Song; Julian Whitelegge; Albert J Courey; James U Bowie
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

5.  Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs.

Authors:  Douglas L Sheridan; Yong Kong; Sirlester A Parker; Kevin N Dalby; Benjamin E Turk
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

6.  Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.

Authors:  Andrea Piserchio; Mangalika Warthaka; Tamer S Kaoud; Kari Callaway; Kevin N Dalby; Ranajeet Ghose
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

7.  Steady-state kinetic mechanism of PDK1.

Authors:  Xinxin Gao; Thomas K Harris
Journal:  J Biol Chem       Date:  2006-05-31       Impact factor: 5.157

8.  DEF pocket in p38α facilitates substrate selectivity and mediates autophosphorylation.

Authors:  Netanel Tzarum; Nadav Komornik; Dorin Ben Chetrit; David Engelberg; Oded Livnah
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

9.  Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine.

Authors:  Mangalika Warthaka; Charles H Adelmann; Tamer S Kaoud; Ramakrishna Edupuganti; Chunli Yan; William H Johnson; Scarlett Ferguson; Clint D Tavares; Lindy J Pence; Eric V Anslyn; Pengyu Ren; Kenneth Y Tsai; Kevin N Dalby
Journal:  ACS Med Chem Lett       Date:  2014-10-17       Impact factor: 4.345

10.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.